肖飛 黃夢(mèng)紅
經(jīng)橈動(dòng)脈介入診治冠心病的價(jià)值評(píng)估與分析
肖飛黃夢(mèng)紅
目的 研究經(jīng)橈動(dòng)脈介入診治冠心病的價(jià)值。方法 將2014年3月~2016年3月在我院接受治療的冠心病患者64例作為對(duì)象,根據(jù)隨機(jī)數(shù)字表法將冠心病患者分為兩組,其中橈動(dòng)脈組、股動(dòng)脈組分別32、32例。股動(dòng)脈組采取經(jīng)股動(dòng)脈介入診治,橈動(dòng)脈組采取經(jīng)橈動(dòng)脈介入診治。就兩組患者手術(shù)成功率、臥床時(shí)間、生活可自理時(shí)間、住院天數(shù)和皮下血腫、排便困難等并發(fā)癥發(fā)生率進(jìn)行比較。結(jié)果 兩組手術(shù)成功率均為100%。橈動(dòng)脈組皮下血腫、排便困難等并發(fā)癥發(fā)生率低于股動(dòng)脈組,P<0.05。橈動(dòng)脈組患者臥床時(shí)間、生活可自理時(shí)間、住院天數(shù)均少于股動(dòng)脈組,P<0.05。結(jié)論 經(jīng)橈動(dòng)脈介入診治冠心病的價(jià)值高,手術(shù)成功率高,且術(shù)后無(wú)需臥床,可減少并發(fā)癥的發(fā)生,加速患者生活自理和縮短住院時(shí)間。
經(jīng)橈動(dòng)脈介入;冠心病;價(jià)值
冠心病是動(dòng)脈血管狹窄導(dǎo)致血液流動(dòng)受阻而出現(xiàn)心臟缺血,引發(fā)的心絞痛癥狀。近年來(lái),隨著冠心病發(fā)病率不斷提升,介入治療因創(chuàng)傷小、操作簡(jiǎn)單,在冠心病治療中發(fā)揮著不可替代的作用[1-2]。本研究探討了經(jīng)橈動(dòng)脈介入診治冠心病的價(jià)值,報(bào)道如下。
1.1一般資料
將2014年3月~2016年3月在我院接受治療的冠心病患者64例作為對(duì)象,根據(jù)隨機(jī)數(shù)字表法將患者分為兩組組,其中橈動(dòng)脈組、股動(dòng)脈組分別32、32例。股動(dòng)脈組男17例,女15例。年齡51~72歲,平均年齡(63.61±2.36)歲。其中,冠心病心絞痛有20例,心肌梗死8例,其他4例。橈動(dòng)脈組男18例,女14例。年齡52~72歲,平均年齡為(63.16±2.22)歲。其中,冠心病心絞痛有19例,心肌梗死9例,其他4例。兩組患者一般資料對(duì)比,P>0.05,差異無(wú)統(tǒng)計(jì)學(xué)意義。
1.2方法
股動(dòng)脈組采取經(jīng)股動(dòng)脈介入診治,平臥位,于腹股溝韌帶下1~2 cm進(jìn)行穿刺,給予1%利多卡因局麻,穿刺針頭斜向近端20°~45°穿刺,成功后插入導(dǎo)絲,并沿著導(dǎo)絲插入股動(dòng)脈鞘管,調(diào)整導(dǎo)管位置,使其在導(dǎo)絲支撐下移動(dòng)至冠脈開(kāi)口處。
橈動(dòng)脈組采取經(jīng)橈動(dòng)脈介入診治,給予Allen試驗(yàn),陽(yáng)性者可進(jìn)行介入治療,從右側(cè)橈動(dòng)脈穿刺,穿刺點(diǎn)在掌橫紋上方0.5~1.0 cm處,給予1%利多卡因局麻,穿刺橈動(dòng)脈成功后將導(dǎo)絲插入,并沿著導(dǎo)絲插入股動(dòng)脈鞘管,調(diào)整導(dǎo)管位置,使其在導(dǎo)絲支撐下移動(dòng)至冠脈開(kāi)口處[3-4]。
1.3觀察指標(biāo)
對(duì)比兩組患者手術(shù)成功率、臥床時(shí)間、生活可自理時(shí)間、住院天數(shù)和皮下血腫、排便困難等并發(fā)癥發(fā)生率。
1.4統(tǒng)計(jì)學(xué)方法
以SPSS21.0軟件處理數(shù)據(jù),計(jì)數(shù)資料用%表示,采用χ2檢驗(yàn),計(jì)量資料用(±s)表示,采用t檢驗(yàn),P<0.05,差異有統(tǒng)計(jì)學(xué)意義。
2.1兩組手術(shù)成功率比較
兩組手術(shù)成功率均為100%。
2.2兩組患者臥床時(shí)間、生活可自理時(shí)間、住院天數(shù)比較
橈動(dòng)脈組患者臥床時(shí)間、生活可自理時(shí)間、住院天數(shù)均少于股動(dòng)脈組,P<0.05。如表1。
表1 兩組患者臥床時(shí)間、生活可自理時(shí)間、住院天數(shù)比較
2.3兩組患者皮下血腫、排便困難等并發(fā)癥發(fā)生率比較
橈動(dòng)脈組皮下血腫、排便困難等并發(fā)癥發(fā)生率低于股動(dòng)脈組,P<0.05。見(jiàn)表2。
表2 兩組患者皮下血腫、排便困難等并發(fā)癥發(fā)生率比較
冠心病急診介入途徑的不同可影響治療效果。其中,經(jīng)股動(dòng)脈介入診治的患者因股動(dòng)脈血管比較粗,操作簡(jiǎn)單,穿刺成功率高,不易出現(xiàn)痙攣,但其與股靜脈、骨神經(jīng)并行,易因穿刺部位不準(zhǔn)確而造成股神經(jīng)損傷、腹膜后出血和動(dòng)靜脈瘺等,且術(shù)后需強(qiáng)制體位,可增加尿潴留、便秘等并發(fā)癥發(fā)生率[5-6]。經(jīng)橈動(dòng)脈介入診治無(wú)伴行主要神經(jīng)血管,不易引發(fā)神經(jīng)血管損傷,可降低手術(shù)風(fēng)險(xiǎn)。此外,手掌以尺動(dòng)脈和橈動(dòng)脈為供血來(lái)源,其中尺動(dòng)脈為主要供血?jiǎng)用},可減少經(jīng)橈動(dòng)脈手術(shù)對(duì)供血循環(huán)的影響。經(jīng)橈動(dòng)脈介入診治術(shù)后無(wú)需臥床休息,可縮短住院時(shí)間,減少下肢靜脈栓塞、血腫等并發(fā)癥發(fā)生,患者耐受良好[7-9]。
本研究中,股動(dòng)脈組采取經(jīng)股動(dòng)脈介入診治;橈動(dòng)脈組采取經(jīng)橈動(dòng)脈介入診治。結(jié)果顯示,兩組手術(shù)均成功,橈動(dòng)脈組皮下血腫、排便困難等并發(fā)癥發(fā)生率低于股動(dòng)脈組,臥床時(shí)間、生活可自理時(shí)間、住院天數(shù)均少于股動(dòng)脈組。
綜上所述,經(jīng)橈動(dòng)脈介入診治冠心病的價(jià)值高,手術(shù)成功率高,且術(shù)后無(wú)需臥床,可減少并發(fā)癥的發(fā)生,加速患者生活自理速度和縮短住院時(shí)間。
[1]閆振嫻,周玉杰,趙迎新,等.應(yīng)用血管內(nèi)超聲探討經(jīng)橈動(dòng)脈介入術(shù)對(duì)橈動(dòng)脈結(jié)構(gòu)和功能的影響[J].臨床心血管病雜志,2010,26(12):894-897.
[2]閆振嫻,周玉杰,趙迎新,等.彩色多普勒超聲評(píng)價(jià)經(jīng)橈動(dòng)脈介入術(shù)對(duì)橈動(dòng)脈結(jié)構(gòu)的影響[J].中國(guó)循環(huán)雜志,2010,25(4):255-258.
[3]馬金生.經(jīng)橈、股動(dòng)脈介入治療慢性左心衰竭冠心病的療效對(duì)比[J].中國(guó)老年學(xué)雜志,2013,33(6):1258-1260.
[4]張賓,高傳玉,李牧蔚,等.經(jīng)橈動(dòng)脈介入治療應(yīng)用維拉帕米和地爾硫卓預(yù)防橈動(dòng)脈痙攣的對(duì)比研究[J].實(shí)用醫(yī)學(xué)雜志,2011,27(11):1978-1980.
[5]馮湘萍,于惠芳,吳澤君,等.兩種止血器在高齡患者經(jīng)橈動(dòng)脈介入術(shù)后的應(yīng)用比較[J].現(xiàn)代臨床護(hù)理,2013,15(8):52-55.
[6]王全蕊,王修美,張華鋒,等.3 327例經(jīng)橈動(dòng)脈介入手術(shù)患者的常見(jiàn)并發(fā)癥[J].中國(guó)老年學(xué)雜志,2016,36(14):3588-3589.
[7]趙冰,李俊峽,鮑宏剛,等.經(jīng)橈動(dòng)脈介入術(shù)后TR Band和RDP-700止血器應(yīng)用的安全性和有效性比較[J].中國(guó)循證心血管醫(yī)學(xué)雜志,2015,22(4):542-543,546.
[8]馬保新,李銀福,史雷忠,等.經(jīng)橈動(dòng)脈介入術(shù)后彈力繃帶小夾板反向固定止血臨床研究[J].心血管康復(fù)醫(yī)學(xué)雜志,2014,23(1):56-58,封3.
[9]張國(guó)春.經(jīng)皮橈動(dòng)脈穿刺介入治療冠心病的療效觀察[J].中國(guó)繼續(xù)醫(yī)學(xué)教育,2015,7(30):98-99.
Evaluation and Analysis of Coronary A rtery D isease in the Diagnosis and Treatm ent of Coronary Artery Disease by Radial Artery Intervention
XIAO Fei HUANG Menghong The First Department of Internal Medicine Cardiovascular, The People's Hospital of Changle County, Changle Shandong 262400, China
Ob jective To study the value of percutaneous coronary intervention in the diagnosis and treatment of coronary heart disease.Methods From March 2014 to March 2016 in our hospital treatment of 64 cases of patients with coronary heart disease as the object, according to the random number table method were divided into two groups of patients with coronary heart disease, of which 32 cases of radial artery group, 32 cases of femoral artery. Femoral artery group was treated by femoral artery intervention, radial artery group was treated by radial artery intervention. The incidence rate of two groups of patients with successful rate of operation, bed time, life can take care of themselves, hospital days and subcutaneous hematoma, defecation difficulties and other complications were compared. Resu lts The success rate of the two groups was 100%. The incidence rate of subcutaneous hematoma and defecation in the radial artery group was lower than that in the femoral artery group, P<0.05. Radial artery group patients in bed time, life can take care of themselves, hospital days were less than the femoral artery group, P<0.05. Conclusion The value of percutaneous coronary intervention for coronary heart disease is high, the success rate of operation is high, and there is no need to stay in bed after operation, which can reduce the incidence of complications, accelerate the life of patients and shorten the length of stay.
Trans radial artery intervention, Coronary heart disease, Value
R 541.4
A
1674-9308(2016)31-0097-03
10.3969/j.issn.1674-9308.2016.31.058
山東省昌樂(lè)縣人民醫(yī)院心內(nèi)一科,山東 昌樂(lè) 262400